| Literature DB >> 30290179 |
Clayton E Friedman1, Quan Nguyen2, Samuel W Lukowski2, Abbigail Helfer1, Han Sheng Chiu1, Jason Miklas3, Shiri Levy3, Shengbao Suo4, Jing-Dong Jackie Han4, Pierre Osteil5, Guangdun Peng6, Naihe Jing7, Greg J Baillie2, Anne Senabouth2, Angelika N Christ2, Timothy J Bruxner2, Charles E Murry3, Emily S Wong8, Jun Ding9, Yuliang Wang10, James Hudson11, Hannele Ruohola-Baker3, Ziv Bar-Joseph9, Patrick P L Tam12, Joseph E Powell13, Nathan J Palpant14.
Abstract
Cardiac differentiation of human pluripotent stem cells (hPSCs) requires orchestration of dynamic gene regulatory networks during stepwise fate transitions but often generates immature cell types that do not fully recapitulate properties of their adult counterparts, suggesting incomplete activation of key transcriptional networks. We performed extensive single-cell transcriptomic analyses to map fate choices and gene expression programs during cardiac differentiation of hPSCs and identified strategies to improve in vitro cardiomyocyte differentiation. Utilizing genetic gain- and loss-of-function approaches, we found that hypertrophic signaling is not effectively activated during monolayer-based cardiac differentiation, thereby preventing expression of HOPX and its activation of downstream genes that govern late stages of cardiomyocyte maturation. This study therefore provides a key transcriptional roadmap of in vitro cardiac differentiation at single-cell resolution, revealing fundamental mechanisms underlying heart development and differentiation of hPSC-derived cardiomyocytes.Entities:
Keywords: CRISPRi; HOPX; cardiomyocytes; development; heart; human pluripotent stem cells; hypertrophy; in silico lineage tracing; scdiff; single-cell RNA-seq
Mesh:
Substances:
Year: 2018 PMID: 30290179 PMCID: PMC6220122 DOI: 10.1016/j.stem.2018.09.009
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633